Market Tracker

09/01 6:05pm ET

Repligen Corp (NASDAQ:RGEN)

19.06
Data as of Aug 29
 -0.57 / -2.90%
Today’s Change
9.41
Today|||52-Week Range
24.68
+39.74%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close19.63
Today’s open19.61
Day’s range19.04 - 19.69
Volume264,907
Average volume (3 months)435,594
Market cap$622.3M
Dividend yield--
Data as of 3:59pm ET, 08/29/2014

Growth & Valuation

Earnings growth (last year)+11.11%
Earnings growth (this year)-46.67%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+9.48%
P/E ratio38.1
Price/Sales6.34
Price/Book5.86

Competitors

 Today’s
change
Today’s
% change
PRTAProthena Corporation...+0.38+1.69%
ASPXAuspex Pharmaceutica...+0.76+3.42%
OMEDOncoMed Pharmaceutic...-1.29-5.98%
MGNXMacroGenics Inc+0.31+1.47%
Data as of 3:59pm ET, 08/29/2014

Financials

Next reporting dateNovember 6, 2014
EPS forecast (this quarter)$0.05
Annual revenue (last year)$68.2M
Annual profit (last year)$16.1M
Net profit margin23.61%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Treasurer, Director &
CAO
Walter C. Herlihy
Chief Operating Officer
Tony J. Hunt
Corporate headquarters
Waltham, Massachusetts

Forecasts